These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11078344)

  • 1. Increased susceptibility to deoxycorticosterone acetate-salt-induced hypertension in endothelin-B-receptor-deficient rats.
    Matsumura Y; Kuro T; Kobayashi Y; Konishi F; Takaoka M; Wessale JL; Opgenorth TJ; Gariepy CE; Yanagisawa M
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S86-9. PubMed ID: 11078344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension.
    Matsumura Y; Kuro T; Kobayashi Y; Konishi F; Takaoka M; Wessale JL; Opgenorth TJ; Gariepy CE; Yanagisawa M
    Circulation; 2000 Nov; 102(22):2765-73. PubMed ID: 11094045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
    Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced blood pressure sensitivity to DOCA-salt treatment in endothelin ET(B) receptor-deficient rats.
    Matsumura Y; Kuro T; Konishi F; Takaoka M; Gariepy CE; Yanagisawa M
    Br J Pharmacol; 2000 Mar; 129(6):1060-2. PubMed ID: 10725252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
    Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salt-sensitive hypertension in endothelin-B receptor-deficient rats.
    Gariepy CE; Ohuchi T; Williams SC; Richardson JA; Yanagisawa M
    J Clin Invest; 2000 Apr; 105(7):925-33. PubMed ID: 10749572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxycorticosterone acetate-salt hypertensive rats display gender-related differences in ET(B) receptor-mediated vascular responses.
    Tostes Passaglia RC; David FL; Fortes ZB; Nigro D; Scivoletto R; Catelli De Carvalho MH
    Br J Pharmacol; 2000 Jul; 130(5):1092-8. PubMed ID: 10882394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats.
    Matsumura Y; Taira S; Kitano R; Hashimoto N; Kuro T
    Biol Pharm Bull; 1999 Aug; 22(8):858-62. PubMed ID: 10480326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
    Johnson RJ; Galligan JJ; Fink GD
    J Hypertens; 2001 Mar; 19(3):431-40. PubMed ID: 11288813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
    Johnson RJ; Fink GD; Watts SW; Galligan JJ
    J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
    Watts SW; Fink GD; Northcott CA; Galligan JJ
    Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin ET(B) receptor-mediated action on systemic and renal hemodynamics and urine formation in deoxycorticosterone acetate-salt-induced hypertensive rats.
    Hashimoto N; Kuro T; Fujita K; Azuma S; Matsumura Y
    Biol Pharm Bull; 1998 Aug; 21(8):800-4. PubMed ID: 9743245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension.
    Hirata Y; Hayakawa H; Suzuki E; Kimura K; Kikuchi K; Nagano T; Hirobe M; Omata M
    Circulation; 1995 Feb; 91(4):1229-35. PubMed ID: 7850963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K; Matsumura Y; Kita S; Miyazaki Y; Hisaki K; Takaoka M; Morimoto S
    Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism.
    Larouche I; Schiffrin EL
    Hypertension; 1999 Oct; 34(4 Pt 2):795-801. PubMed ID: 10523363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Ueda M; Tatsumi Y; Yoshikawa J
    Metabolism; 1997 Sep; 46(9):1032-8. PubMed ID: 9284892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
    Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.
    David FL; Carvalho MH; Cobra AL; Nigro D; Fortes ZB; Rebouças NA; Tostes RC
    Hypertension; 2001 Sep; 38(3 Pt 2):692-6. PubMed ID: 11566958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension.
    Li L; Fink GD; Watts SW; Northcott CA; Galligan JJ; Pagano PJ; Chen AF
    Circulation; 2003 Feb; 107(7):1053-8. PubMed ID: 12600921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.